Back to Journals » Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4447)
- Volume 21, 2025 (113)
- Volume 20, 2024 (228)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Journal Articles:
- Closing the Mortality Gap: Novel Approaches to Improve Physical Health and Quality of Life among People with Mental Illness (2)
- The effectiveness of non-pharmacological interventions for people with cognitive dysfunction (2)
- Advanced Neurorestoratology: Basic and Clinical Research (2)
- Autism, the disorder without borders and geopolitical variations (12)
- All about Psychogenic Non-Epileptic Seizures (PNES) and Functional Neurological Disorders (FND) (1)
- Cognitive dysfunction in bipolar disorder: Bio-psycho-social perspective (2)
- Current Insights into the Epidemiology, Risk Factors, Treatment and Management Options of Seizures and Epilepsy After Stroke (1)
- Epileptic disorders: advances in the diagnostic and therapeutic strategies (3)
- Beneath the surface: genetic factors in schizophrenia (3)
- Stroke and neurorestoratology (1)
- Suicide Prevention and Intervention: Recent Evidence and Future Directions (4)
- Family and Peer Facilitated/Led Interventions for Severe Mental Health Problems (2)
- Therapeutic Response to Psychedelic Therapy – Who, What, Why & How? (3)
- Current Perspectives of Chronic Stress: from Neurobiology to Treatment (3)
- Issues and Solutions in Autism Spectrum Disorders (ASD) (9)
- Cariprazine in schizophrenia (5)
- The Caregiver Perspective on Pediatric ADHD (3)
- Volume 7 - Supplement 1 (5)
- Volume 6 - Supplement 1 (6)

An Effectiveness Trial of an Exercise Physiologist Service to Improve Quality of Life in Adults with Severe Mental Illness: Protocol for the MOVEMENT Study
Chapman JJ, Siskind D, Yung AR, Lee YY, Arnautovska U, Scott JG, Burke K, Malacova E, Korman N, Wyder M, Doohan MA, Keating SE, Parker S, Walker ME, Hu D, O’Brien J, Lau G, Pratt GF, Rosenbaum S, Curtis J, Chatterton ML, Simmons L, Wheeler AJ
Neuropsychiatric Disease and Treatment 2025, 21:1399-1408
Published Date: 11 July 2025

A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMART
Arnautovska U, Ritchie G, Soole R, Menon A, Korman N, Milton A, Varnfield M, Kelly JT, Jansen PM, Baker A, Ireland D, Russell AW, Chapman J, Mulligan K, Hirani SP, Vitangcol KJ, McKeon G, Siskind D
Neuropsychiatric Disease and Treatment 2025, 21:1289-1305
Published Date: 26 June 2025

An Evaluation a PrEP-Focused HIV Prevention Intervention Tailored for Individuals with Opioid Use Disorder and Cognitive Dysfunction
Mistler CB, Huedo-Medina TB, Shrestha R, Gunstad J, Zelenev A, Copenhaver MM
Neuropsychiatric Disease and Treatment 2025, 21:1235-1248
Published Date: 24 June 2025

Characteristics of Parthenogenetic Stem Cells and Their Potential Treatment Strategy for Central Nervous System Diseases
Cai H, Huang J, Wang W, Lin W, Ahmed W, Lu D, Quan J, Chen L
Neuropsychiatric Disease and Treatment 2025, 21:213-227
Published Date: 3 February 2025

Multimodal Magnetic Resonance Findings in Parkinson’s Disease With “Antecedent Essential Tremor”: A Case Series of a Large Kindred
Kong Y, Yao L, Xiao X, Chen A, Wang K, Yan H, Sun R, Liu R, Kong Q
Neuropsychiatric Disease and Treatment 2025, 21:79-92
Published Date: 22 January 2025

Autism Prevalence Information And Diagnosis Processes In Cyprus, Greece And Malta
Petinou K, Vogindroukas I, Christopoulou M
Neuropsychiatric Disease and Treatment 2024, 20:2499-2505
Published Date: 12 December 2024

Psychiatric Comorbidities in Functional Neurological Disorders and Psychogenic Non-Epileptic Seizures: A Systematic Review and Policy Recommendations for Improving Assessment and Treatment
Lazzari C, Nikolou-Walker E, Liu LQ, Rabottini M
Neuropsychiatric Disease and Treatment 2024, 20:2313-2331
Published Date: 27 November 2024

Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials: Antidepressants for Restricted and Repetitive Behaviors in Autism Spectrum Disorder
Maneeton P, Maneeton B, Winichaikul Y, Kawilapat S, Kienngam N, Maneeton N
Neuropsychiatric Disease and Treatment 2024, 20:1711-1723
Published Date: 2 October 2024

Building Bridges! Children with Autism Spectrum Disorder and Their Transition from Kindergarten to School – A Scoping Review
Chahboun S, Lefstad KT, Pettersen M, Åmot I, Thwala S
Neuropsychiatric Disease and Treatment 2024, 20:1823-1835
Published Date: 27 September 2024

Circulating Cell-Free Mitochondrial DNA in Plasma of Individuals with Schizophrenia and Cognitive Deficit in Mexican Population
Garcia-de la Cruz DD, Juarez-Rojop IE, Tovilla-Zarate CA, Nicolini H, Genis-Mendoza AD
Neuropsychiatric Disease and Treatment 2024, 20:1757-1765
Published Date: 21 September 2024

The Face of Autism in Israel
Ferman S, Segal O
Neuropsychiatric Disease and Treatment 2024, 20:1677-1692
Published Date: 7 September 2024


Risk Factors for Post-Stroke Seizures in a Tertiary Care Center: A Case–Control Study
Mohamed AA, Tan JK, Tan MM, Khoo CS, Wan Yahya WNN, Abd Rahman MSH, Sutan R, Tan HJ
Neuropsychiatric Disease and Treatment 2024, 20:1615-1628
Published Date: 26 August 2024


Prevalence of Autism in Scandinavian Countries (Denmark, Norway, Sweden), and Nordic Countries (Finland, Iceland, the Faroe Islands, and Greenland)
Jensen de López KM, Thirup Møller H
Neuropsychiatric Disease and Treatment 2024, 20:1597-1612
Published Date: 19 August 2024

Developing Knowledge of Autism in Majority World Countries: Examples of Bolivia and Paraguay
Westby C, Roman R
Neuropsychiatric Disease and Treatment 2024, 20:1583-1595
Published Date: 15 August 2024

Reimagining Support for Autistic Indigenous Children in the United States: Addressing Under-Identification and Service Gaps
Kristofik A, Demps KL
Neuropsychiatric Disease and Treatment 2024, 20:1503-1511
Published Date: 2 August 2024


Autism in Taiwan and Thailand: Influences of Culture
Westby C, Chen KM, Cheng L, Jithavech P, Maroonroge S
Neuropsychiatric Disease and Treatment 2024, 20:1523-1538
Published Date: 2 August 2024

Benefits of Combining Antiepileptic Drugs with Vitamin B12 on Redox Balance: Penicillin-Induced Experimental Epilepsy Model
Taskin S, Ozsoy S, Cakir Z
Neuropsychiatric Disease and Treatment 2024, 20:1271-1277
Published Date: 12 June 2024


Cognition in Euthymic Patients with Bipolar Disorder: Do Not Forget to Account for Anxiety!


Yoldi-Negrete M, Fresán A, Jiménez-Rodríguez LI, Tirado-Durán EG
Neuropsychiatric Disease and Treatment 2024, 20:1181-1189
Published Date: 4 June 2024


The Unmasking of Autism in South Africa and Nigeria
Adams SN
Neuropsychiatric Disease and Treatment 2024, 20:947-955
Published Date: 8 May 2024

Ensemble Learning for Higher Diagnostic Precision in Schizophrenia Using Peripheral Blood Gene Expression Profile
Wagh VV, Kottat T, Agrawal S, Purohit S, Pachpor TA, Narlikar L, Paralikar V, Khare SP
Neuropsychiatric Disease and Treatment 2024, 20:923-936
Published Date: 3 May 2024

Efficacy of Personalized Postoperative Epilepsy Management in Patients with Glioblastoma Utilizing IDH1 Gene Assessment
Meng GQ, Chen S, Ye HB, Ma BJ, Tao S, Ye Z
Neuropsychiatric Disease and Treatment 2024, 20:855-862
Published Date: 12 April 2024

Neuropsychiatric Symptoms Predict Faster Cognitive Decline in Dementia Collaborative Care Than Antipsychotic Use
Chen YJ, Chang MC, Jhang KM, Wang WF, Liao YC
Neuropsychiatric Disease and Treatment 2024, 20:689-696
Published Date: 26 March 2024

Endovascular Thrombectomy for Acute Ischemic Stroke in Indonesia: Challenging and Strategic Planning
Rilianto B, Kurniawan RG, Rajab NM, Prasetyo BT
Neuropsychiatric Disease and Treatment 2024, 20:621-630
Published Date: 21 March 2024

Validity and Reliability Study of the Turkish Version of the Orbach Mikulincer Mental Pain Scale-8 in a Clinical Population
Demirkol ME, Tamam L, Namlı Z, Yeşiloğlu C, Yılmaz H
Neuropsychiatric Disease and Treatment 2024, 20:429-438
Published Date: 1 March 2024

Hormonal Changes in Women with Epilepsy
Li Q, Zhang Z, Fang J
Neuropsychiatric Disease and Treatment 2024, 20:373-388
Published Date: 26 February 2024

What Do Farmers Need for Suicide Prevention: Considerations for a Hard-to-Reach Population
Scheyett A, Marburger IL, Scarrow A, Hollifield SM, Dunn JW
Neuropsychiatric Disease and Treatment 2024, 20:341-352
Published Date: 22 February 2024

A Thematic Analysis Investigating the Inaugural Psychosis REACH Family Ambassador Peer Training Program
Vaswani-Bye A, McCain C, Blank JM, Tennison ME, Kopelovich SL
Neuropsychiatric Disease and Treatment 2024, 20:233-245
Published Date: 8 February 2024

Excess Mortality in Individuals with Autism Spectrum Disorder: A Population-Based Cohort Study
Huang YH, Wu SI, Lee MJ, Chen YL, Yang YH, Kuo TY, Hung TH, Dewey ME, Stewart R, Chen VCH
Neuropsychiatric Disease and Treatment 2024, 20:247-255
Published Date: 8 February 2024


The Inter-Relationships Between Depressive Symptoms and Suicidality Among Macau Residents After the “Relatively Static Management” COVID-19 Strategy: A Perspective of Network Analysis
Lam MI, Cai H, Chen P, Lok KI, Chow IHI, Si TL, Su Z, Ng CH, An FR, Xiang YT
Neuropsychiatric Disease and Treatment 2024, 20:195-209
Published Date: 3 February 2024

Effect of Object on Kinesthetic Motor Imagery in Autism Spectrum Disorder: A Pilot Study Based on Eye-Tracking Methodology
Liu Y, Hu J
Neuropsychiatric Disease and Treatment 2024, 20:167-183
Published Date: 24 January 2024


Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions
Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V
Neuropsychiatric Disease and Treatment 2024, 20:109-135
Published Date: 20 January 2024


NR3C1 and NR3C2 Genes Increase the Risk of Suicide Attempt in Psychiatric Disorder Patients with History of Childhood Trauma
Sanabrais-Jiménez MA, Esquivel-López AA, Sotelo-Ramírez CE, Aguilar-García A, Ordoñez-Martínez B, Jiménez-Pavón J, Madrigal-Lara MV, Díaz-Vivanco AJ, Camarena B
Neuropsychiatric Disease and Treatment 2023, 19:2561-2571
Published Date: 24 November 2023

Genetic Susceptibility to Tardive Dyskinesia and Cognitive Impairments in Chinese Han Schizophrenia: Role of Oxidative Stress-Related and Adenosine Receptor Genes
Jiang Q, Zhang X, Lu X, Li Y, Lu C, Chi J, Ma Y, Shi X, Wang L, Li S
Neuropsychiatric Disease and Treatment 2023, 19:2499-2509
Published Date: 20 November 2023

Frozen in Time, a Focused Review of Autism Prevalence in Canadian Indigenous Communities
Hus Y
Neuropsychiatric Disease and Treatment 2023, 19:2451-2468
Published Date: 16 November 2023


Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis
Ko K, Carter B, Cleare AJ, Rucker JJ
Neuropsychiatric Disease and Treatment 2023, 19:2105-2113
Published Date: 5 October 2023

Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study
Chiappini S, Di Carlo F, Mosca A, d'Andrea G, Di Paolo M, Lorenzini C, Lupica MG, Sampogna G, Pettorruso M, Fiorillo A, Martinotti G
Neuropsychiatric Disease and Treatment 2023, 19:1887-1897
Published Date: 30 August 2023

Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia
Cao Y, Xu Y, Xia Q, Shan F, Liang J
Neuropsychiatric Disease and Treatment 2023, 19:1455-1462
Published Date: 23 June 2023


Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders
Kanes SJ, Dennie L, Perera P
Neuropsychiatric Disease and Treatment 2023, 19:811-828
Published Date: 12 April 2023


Use of Selective Alternative Therapies for Treatment of OCD
Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A
Neuropsychiatric Disease and Treatment 2023, 19:721-732
Published Date: 5 April 2023


Impact of Childhood Adversity, as Early Life Distress, on Cytokine Alterations in Schizophrenia
Miljevic C, Munjiza-Jovanovic A, Jovanovic T
Neuropsychiatric Disease and Treatment 2023, 19:579-586
Published Date: 11 March 2023


Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study
Hurşitoğlu O, Kurutas EB, Strawbridge R, Uygur OF, Yildiz E, Reilly TJ
Neuropsychiatric Disease and Treatment 2022, 18:2519-2527
Published Date: 2 November 2022


The Efficacy of Head-Mounted-Display Virtual Reality Intervention to Improve Life Skills of Individuals with Autism Spectrum Disorders: A Systematic Review
Skjoldborg NM, Bender PK, Jensen de López KM
Neuropsychiatric Disease and Treatment 2022, 18:2295-2310
Published Date: 17 October 2022


Focus on Issues and Solutions in Autism Spectrum Disorders (ASD)
Petinou K, Hus Y, Segal O
Neuropsychiatric Disease and Treatment 2022, 18:2273-2277
Published Date: 17 October 2022



Nature and Effects of Autobiographical Memory Issues in Persons with Autism Spectrum Disorders


Westby C
Neuropsychiatric Disease and Treatment 2022, 18:2279-2293
Published Date: 17 October 2022



Rehabilitation Services for Young Adults with ASD


Kristofik A, Johnson KL
Neuropsychiatric Disease and Treatment 2022, 18:2361-2366
Published Date: 17 October 2022


Recent Advances of Telepractice for Autism Spectrum Disorders in Speech and Language Pathology
Christopoulou M, Drosos K, Petinou K
Neuropsychiatric Disease and Treatment 2022, 18:2379-2389
Published Date: 14 October 2022


Language and Speech Characteristics in Autism
Vogindroukas I, Stankova M, Chelas EN, Proedrou A
Neuropsychiatric Disease and Treatment 2022, 18:2367-2377
Published Date: 14 October 2022


Feeding and Swallowing Issues in Autism Spectrum Disorders
Adams SN
Neuropsychiatric Disease and Treatment 2022, 18:2311-2321
Published Date: 14 October 2022


Comparing Theory of Mind Development in Children with Autism Spectrum Disorder, Developmental Language Disorder, and Typical Development
Schwartz Offek E, Segal O
Neuropsychiatric Disease and Treatment 2022, 18:2349-2359
Published Date: 14 October 2022


Detecting Time Concept Competence in Children with Autism Spectrum and Attention Disorders
Hus Y
Neuropsychiatric Disease and Treatment 2022, 18:2323-2348
Published Date: 14 October 2022


Cariprazine on Psychosis: Beyond Schizophrenia – A Case Series
Bajouco M, Mota D
Neuropsychiatric Disease and Treatment 2022, 18:1351-1362
Published Date: 5 July 2022


Cariprazine in Three Special Different Areas: A Real-World Experience
Gesi C, Paletta S, Palazzo M C, Dell'Osso B, Mencacci C, Cerveri G
Neuropsychiatric Disease and Treatment 2021, 17:3581-3588
Published Date: 7 December 2021


Cariprazine: Patients with Treatment-Resistant Schizophrenia
Aubel T
Neuropsychiatric Disease and Treatment 2021, 17:2327-2332
Published Date: 14 July 2021


Decline in Psychotic Symptoms in Addition to Cardiac and Metabolic Safety with Cariprazine After Poor Response to Previous Antipsychotic Treatments – A Series of Two Cases
Müller HHO, Moeller S
Neuropsychiatric Disease and Treatment 2021, 17:1089-1093
Published Date: 15 April 2021


Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience
Montes JM, Montes P, Hernández-Huerta D
Neuropsychiatric Disease and Treatment 2021, 17:291-296
Published Date: 3 February 2021


Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
Fridman M, Banaschewski T, Sikirica V, Quintero J, Chen KS
Neuropsychiatric Disease and Treatment 2017, 13:947-958
Published Date: 30 March 2017


Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control
Fridman M, Banaschewski T, Sikirica V, Quintero J, Erder MH, Chen KS
Neuropsychiatric Disease and Treatment 2017, 13:443-455
Published Date: 13 February 2017


Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe
Fridman M, Banaschewski T, Sikirica V, Quintero J, Erder MH, Chen KS
Neuropsychiatric Disease and Treatment 2017, 13:373-386
Published Date: 7 February 2017


The noradrenergic symptom cluster: clinical expression and neuropharmacology
Blier P, Briley M
Neuropsychiatric Disease and Treatment 2011, 7:15-20
Published Date: 3 June 2011


Improvement of the noradrenergic symptom cluster following treatment with milnacipran
Kasper S, Meshkat D, Kutzelnigg A
Neuropsychiatric Disease and Treatment 2011, 7:21-27
Published Date: 31 May 2011


Noradrenergic symptom cluster in depression
Montgomery S, Briley M
Neuropsychiatric Disease and Treatment 2011, 7:1-2
Published Date: 31 May 2011


The increasing burden of depression
Lépine J-P, Briley M
Neuropsychiatric Disease and Treatment 2011, 7:3-7
Published Date: 31 May 2011


The importance of norepinephrine in depression
Moret C, Briley M
Neuropsychiatric Disease and Treatment 2011, 7:9-13
Published Date: 31 May 2011


Milnacipran: a unique antidepressant?
Siegfried Kasper, Gerald Pail
Neuropsychiatric Disease and Treatment 2010, 6:23-31
Published Date: 25 August 2010


Antidepressant therapy with milnacipran and venlafaxine
Lucilla Mansuy
Neuropsychiatric Disease and Treatment 2010, 6:17-22
Published Date: 25 August 2010


Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
Peter Hofmann
Neuropsychiatric Disease and Treatment 2010, 6:9-15
Published Date: 25 August 2010


Milnacipran: recent findings in depression
Guest editors: Stuart Montgomery (London, UK) and Mike Briley (Castres, France)
Neuropsychiatric Disease and Treatment 2010, 6:0-0
Published Date: 24 August 2010


Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
Philippe Courtet
Neuropsychiatric Disease and Treatment 2010, 6:3-8
Published Date: 24 August 2010


Editorial Foreword - Milnacipran: recent findings in depression
Stuart Montgomery, Mike Briley
Neuropsychiatric Disease and Treatment 2010, 6:1-2
Published Date: 24 August 2010